loadpatents
name:-0.012405872344971
name:-0.012501955032349
name:-0.0073349475860596
Pletnev; Alexander G. Patent Filings

Pletnev; Alexander G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pletnev; Alexander G..The latest application filed is for "construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus".

Company Profile
6.11.9
  • Pletnev; Alexander G. - Gaithersburg MD
  • Pletnev; Alexander G. - Rockville MD US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 11,400,150 - Pletnev , et al. August 2, 2
2022-08-02
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus
App 20210069317 - Pletnev; Alexander G. ;   et al.
2021-03-11
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 10,869,920 - Pletnev , et al. December 22, 2
2020-12-22
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile
App 20200030435 - Pletnev; Alexander G. ;   et al.
2020-01-30
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 10,456,461 - Pletnev , et al. Oc
2019-10-29
Live Attenuated Zika Virus Vaccine
App 20190194260 - Whitehead; Stephen S. ;   et al.
2019-06-27
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus
App 20180369358 - Pletnev; Alexander G. ;   et al.
2018-12-27
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 10,058,602 - Pletnev , et al. August 28, 2
2018-08-28
Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
Grant 9,238,799 - Pletnev , et al. January 19, 2
2016-01-19
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus
App 20140294892 - Pletnev; Alexander G. ;   et al.
2014-10-02
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
Grant 8,778,671 - Pletnev , et al. July 15, 2
2014-07-15
Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses
App 20140004147 - Pletnev; Alexander G. ;   et al.
2014-01-02
Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
Grant 8,568,739 - Pletnev , et al. October 29, 2
2013-10-29
Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses
App 20120076821 - Pletnev; Alexander G. ;   et al.
2012-03-29
Chimeric Sle/dengue Type 4 Antigenic Viruses
App 20100316670 - Blaney; Joseph E. ;   et al.
2010-12-16
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
App 20050100886 - Pletnev, Alexander G. ;   et al.
2005-05-12
Chimeric and/or growth-restricted flaviviruses
Grant 6,676,936 - Lai , et al. January 13, 2
2004-01-13
Chimeric and/or growth-restricted flaviviruses
Grant 6,184,024 - Lai , et al. February 6, 2
2001-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed